Patents by Inventor Sylvie Freeman

Sylvie Freeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DETECTION OF ACUTE MYELOID LEUKAEMIA
    Publication number: 20240280560
    Abstract: The present invention relates to diagnostic screens, antibodies, methods and kits for detection/prognosis of acute myeloid leukaemia. The diagnostic screen detects the presence (+) or absence (?) of the cell surface polypeptide markers i) CD34+; ii) CD45RA+; and iii) CD90? and/or CD123+. Antibodies specific for one or more of said cell surface polypeptide markers may be used in the diagnostic screen of the invention. Diagnostic and prognostic methods for detecting and monitoring minimal residual disease based on said screen also form part of the invention.
    Type: Application
    Filed: August 17, 2023
    Publication date: August 22, 2024
    Inventors: Paresh Vyas, Nicolas Goardon, Sylvie Freeman
  • DETECTION OF ACUTE MYELOID LEUKAEMIA
    Publication number: 20180299427
    Abstract: The present invention relates to diagnostic screens, antibodies, methods and kits for detection/prognosis of acute myeloid leukaemia. The diagnostic screen detects the presence (+) or absence (?) of the cell surface polypeptide markers i) CD34+; ii) CD45RA+; and iii) CD90? and/or CD123+. Antibodies specific for one or more of said cell surface polypeptide markers may be used in the diagnostic screen of the invention. Diagnostic and prognostic methods for detecting and monitoring minimal residual disease based on said screen also form part of the invention.
    Type: Application
    Filed: December 14, 2017
    Publication date: October 18, 2018
    Inventors: Paresh Vyas, Nicolas Goardon, Sylvie Freeman
  • DETECTION OF ACUTE MYELOID LEUKAEMIA
    Publication number: 20130337474
    Abstract: The present invention relates to diagnostic screens, antibodies, methods and kits for detection/prognosis of acute myeloid leukaemia. The diagnostic screen detects the presence (+) or absence (?) of the cell surface polypeptide markers i) CD34+; ii) CD45RA+; and iii) CD90? and/or CD123+. Antibodies specific for one or more of said cell surface polypeptide markers may be used in the diagnostic screen of the invention. Diagnostic and prognostic methods for detecting and monitoring minimal residual disease based on said screen also form part of the invention.
    Type: Application
    Filed: December 21, 2011
    Publication date: December 19, 2013
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Paresh Vyas, Nicolas Goardon, Sylvie Freeman